T45.602D Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter

Name of the Condition

• Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter (ICD-10 code: T45.602D)

Summary

This condition represents intentional self-harm involving poisoning by unspecified fibrinolysis-affecting drugs during a subsequent encounter. Fibrinolysis-affecting drugs modify the body’s clot-dissolving processes, and intentional poisoning can disrupt hemostasis, leading to bleeding or other systemic effects. The term "subsequent encounter" indicates ongoing care for the same episode of poisoning.

Causes

Intentional self-harm poisoning occurs when an individual deliberately ingests, injects, or exposes themselves to fibrinolysis-affecting drugs. This may result from suicidal intent, misuse, or intentional overdose. Underlying factors like mental health conditions, substance use, or access to these medications can contribute.

Risk Factors

• History of suicidal ideation or prior self-harm attempts.
• Access to fibrinolysis-affecting drugs (e.g., in clinical or household settings).
• Concurrent mental health disorders (e.g., depression, anxiety).
• Substance use disorders involving prescription or illicit drugs.
• Social or environmental stressors increasing self-harm risk.

Symptoms

• Uncontrolled or excessive bleeding (e.g., bruising, nosebleeds, gastrointestinal hemorrhage).
• Prolonged bleeding from minor injuries or procedures.
• Low blood pressure, dizziness, or shock in severe cases.
• Abdominal pain, nausea, or vomiting.
• Neurological symptoms (e.g., confusion, headache) in severe toxicity.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, history of intentional exposure, and laboratory tests to assess bleeding risk (e.g., coagulation studies). Imaging may be used to detect internal bleeding. Documentation of self-harm intent and subsequent encounter status is critical for coding.

Treatment Options

Treatment focuses on stabilizing the patient, reversing drug effects (if possible), and managing bleeding. Interventions may include supportive care, blood product transfusions, or antidotes. Psychiatric evaluation and safety planning are essential for intentional self-harm cases.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timely intervention, and underlying mental health support. Follow-up includes monitoring for recurrent bleeding, medication adjustments, and ongoing psychiatric care to address self-harm risk.

Complications

• Severe or life-threatening bleeding (e.g., intracranial hemorrhage).
• Organ damage from hypotension or ischemia.
• Long-term psychological effects of self-harm.
• Recurrence of intentional poisoning without intervention.

Lifestyle & Prevention

• Secure storage of fibrinolysis-affecting drugs to limit access.
• Mental health support and crisis intervention for at-risk individuals.
• Education on medication safety and self-harm prevention.
• Regular follow-up with healthcare providers for chronic conditions.

When to Seek Professional Help

Seek immediate medical attention for symptoms of uncontrolled bleeding, severe pain, or signs of shock. Prompt care is critical to prevent life-threatening complications. Psychiatric evaluation is recommended for intentional self-harm to address underlying risks.

Tips for Medical Coders

Document the intent (intentional self-harm) and encounter type (subsequent) clearly. Ensure the poisoning is attributed to unspecified fibrinolysis-affecting drugs and that the episode of care aligns with the "subsequent encounter" definition. Verify no other codes better describe the scenario.